chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The swelling in his foot and ankle, he is not sure if this pre-dates the the first doses of the Covid vaccine.; The swelling in his foot and ankle, he is not sure if this pre-dates the the first doses of the Covid vaccine.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 79 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 26Jan2021 (Lot number: EK9231) at the age of 79 years as dose 1, single and administered in arm left, administration date 16Feb2021 (Lot number: EL9266) as dose 2, single for covid-19 immunisation. Relevant medical history included: "increase in weight" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: JOINT SWELLING (non-serious), PERIPHERAL SWELLING (non-serious) all with onset 2021, outcome "unknown" and all described as "The swelling in his foot and ankle, he is not sure if this pre-dates the the first doses of the Covid vaccine.". Therapeutic measures were taken as a result of joint swelling, peripheral swelling.  Additional information: History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available): none provided. Additional Vaccines Administered on Same Date of the Pfizer Suspect:  none. Other Products, Patient History and Investigation Assessment was reported as No. Prior Vaccinations (within 4 weeks) and Patients Medical History (including any illness at time of vaccination): none. Weight- he states he has an increase in weight in but this was before the last dose, it started more than a year this has been going on before any of the vaccines. medication change- he had a problem with swelling in his left foot and ankle. when it gets really swollen his cardiologist has him take a half a pill of furosemide, he was on this for about a week and stopped 2 days ago but is not sure when started it. The swelling in his foot and ankle, he is not sure if this pre-dates the the first doses of the Covid vaccine. Adverse events did not result in Emergency room visit or physician office visit. Relevant tests was reported as none.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101281330 similar report from same reporter
Slight soreness in upper left arm near injection site.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53-year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 18Mar2021 09:00 (Lot number: EP6955) at the age of 53 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "High blood pressure" (unspecified if ongoing), notes: verbatim:High blood pressure. Concomitant medication(s) included: ACCUPRIL; NORVASC. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 18Mar2021 13:00, outcome "recovered" (Mar2021), described as "Slight soreness in upper left arm near injection site.". Therapeutic measures were not taken as a result of vaccination site pain.   Additional information: Patient did not receive any other vaccines in 4 week, Prior to vaccination and post vaccination, the patient was not diagnosed with COVID-19 and patient had no allergy to medications, food, or other products. Soreness aware on March 18, 2021  No follow-up attempts are possible. No further information is expected.
Sore throat; Terrible stomachaches; Decreased appetite; Very bad headache; This is a spontaneous report from a contactable consumer, the patient. An 18-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 17Apr2021 at 11:30 (at the age of 18-year-old) as a single dose for COVID-19 immunisation. The patient's medical history included anxiety, depression and gluten sensitivity. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication taken within two weeks of vaccination was not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Apr2021, the patient experienced very bad headache for two days, terrible stomach aches that were still occurring non-stop after eight days and decreased appetite. On 19Apr2021, two days after the vaccination, the patient experienced sore throat.  The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event very bad headache was recovered on 19Apr2021. The clinical outcome of the event sore throat was recovered on 21Apr2021. The clinical outcome of the events terrible stomach aches and decreased appetite were not recovered at the time of reporting. No follow-up attempts are needed. No further information is expected.
Patient received 0.2mg of diluted 5-11 year old pediatric Covid -19 Pfizer. Patient is not old enough to receive this. Patient had on symptoms. Parent is aware.
Sugar level was high; Sore in arm; This spontaneous case was reported by a consumer and describes the occurrence of HYPERGLYCAEMIA (Sugar level was high) and PAIN IN EXTREMITY (Sore in arm) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Brain operation in November 2020. Concurrent medical conditions included Diabetes. Concomitant products included INSULIN for Diabetes.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced HYPERGLYCAEMIA (Sugar level was high) and PAIN IN EXTREMITY (Sore in arm). At the time of the report, HYPERGLYCAEMIA (Sugar level was high) outcome was unknown and PAIN IN EXTREMITY (Sore in arm) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment details were provided.  Patient used the pen needle. Patient always get paranoid and Schedule for second shot on 20-Feb-2021.
Fever of 102 Chills  Body ache and arthritic pain Headache  Lasted until morning or 3/28.
pt recv vax 6JUN96 & became pregnant (LMP 12JUL96; estimated date of conception 26JUL96); pt elected to terminate the pregnancy;no further details are expected;
sore arm [after first dose]; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm [after first dose]) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm [after first dose]). At the time of the report, PAIN IN EXTREMITY (sore arm [after first dose]) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment information were reported by the reporter   This case was linked to MOD-2022-437834 (Patient Link).
pt recv vax 15MAY97 & 1wk p/vax pt exp swelling & pain of the parotid gland;8JUL97 pt exp testicular swelling;
headache; stomach pain; dizziness; trouble concentrating; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 16Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious) with onset 16Mar2021, outcome "unknown", described as "headache"; ABDOMINAL PAIN UPPER (non-serious) with onset 16Mar2021, outcome "unknown", described as "stomach pain"; DIZZINESS (non-serious) with onset 16Mar2021, outcome "unknown", described as "dizziness"; DISTURBANCE IN ATTENTION (non-serious) with onset 16Mar2021, outcome "unknown", described as "trouble concentrating".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
4/22 COVID VACCINE FIRST DOSE GIVEN, POST VACCINATION REPORTS DIZZINESS, FATIGUE, CHILLS. 4/23 DIARRHEA INTIATES 4/25 20:13 PRESENTS TO ED AFTER A FALL AT HOME, HUSBAND FOUND, UNKNOWN DOWN TIME.  PT REPORTS  DIZZINESS, FATIGUE, CHILLS, X3 DAYS DIARRHEA X 2DAYS.
11/19/21 presents to ED for "difficulty speaking correctly or making sentences". PMHx of "astrocytoma".
Pt appt 11:15. Pt arrival at clinic after vaccinations at 1300 with complaints of red, blotchy rash on cheeks and trunk of his body with itching. Cheeks swollen, eyes slightly swollen. Gave 25mg Benadryl 1300. Monitored vital signs for 45 minutes, sent to hospital for continual monitoring.
Severe headache, myalgias, lethargy. BOOSTRIX and MENACTRA 8/20/08, seen 8/21/08 in the office, 8/22/08; still has a headache, muscle pain, lethargy.
headache; feeling sick enough; pressure in my head & sinuses; pressure in my head & sinuses; felt very exhausted; my (left) arm is still extremely sore; feeling sick enough to need to lay down & could not continue working/impossible to work or get up; I just felt horrible, & oddly; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 68 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 05Mar2021 11:30 (Batch/Lot number: unknown) at the age of 68 years as dose 1, single for covid-19 immunisation. Relevant medical history included flu (unspecified if ongoing); cold (unspecified if ongoing). There were no concomitant medications. The following information was reported HEADACHE (non-serious) with onset 05Mar2021 13:30, outcome recovering; MALAISE (non-serious) with onset 05Mar2021 13:30, outcome recovering; HEAD DISCOMFORT (non-serious), PARANASAL SINUS DISCOMFORT (non-serious) all with onset 05Mar2021 13:30, outcome recovering; FATIGUE (non-serious) with onset 05Mar2021 13:30, outcome recovering; VACCINATION SITE PAIN (non-serious) with onset 05Mar2021 13:30, outcome not recovered; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious) with onset 05Mar2021 13:30, outcome recovering; FEELING ABNORMAL (non-serious) with onset 05Mar2021 13:30, outcome recovering. Therapeutic measures were not taken as a result of headache, malaise, head discomfort, paranasal sinus discomfort, fatigue, vaccination site pain, loss of personal independence in daily activities, feeling abnormal.  Facility type vaccine was other. No other vaccine in four weeks. No other medications in two weeks. Beginning about 70-90 minutes after her first injection she started feeling sick enough to need to lay down & could not continue working. She had symptoms like she never had before during flu or cold & they were hard to describe. She felt headache, & pressure in her head & sinuses & felt very exhausted. In general, she just felt horrible, & oddly, laying down did not help her feel better & it was hard to rest through the symptoms, but impossible to work or get up. The symptoms lasted at the same severity for 35-36 hours after which, she felt fine. However, her (left) arm was still extremely sore & not yet improving significantly after 4 days. She was very surprised by her reaction as she had never reacted to any other vaccination. No covid prior vaccination. The patient was not covid tested post vaccination. No known allergies.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
Patient got a FLUZONE HD shot on 9/9/15. Patient came to store to inquire about reaction to arm. Patient proceeded to primary care for treatment. Antibiotics given to patient for cellulitis.
About 20 hrs after injection-woke up with extreme ataxia and sl blurry/glazed vision. Had to leave work early.
This spontaneous report as received from a consumer refers to her 5 years old daughter. On an unknown date, the patient was vaccinated with a dose of MMR II (dose, route, strength, lot# and expiration date not reported). The reporter stated that as a result of blood test performed on 09-MAY-2014 (also reported that there was no lab diagnostic studies performed), it was determined that the patient did not have immunity against mumps after receiving MMR II. There was no treatment given for the event. The patient did not seek any medical attention. The outcome of the event was unknown. The relatedness between the event and MMR II was not reported. Additional information has been requested.
difficult sleeping; light sensitive; trouble eating; sinus infection; her face hurts so bad; Loose stools; almost blinding/vision was so bad; Headache; Nausea; In back of head and front of eyes, feels like it's bulging; Pfizer COVID-19 Booster injection; Pfizer COVID-19 Booster injection; This is a spontaneous case from a contactable nurse (patient). This 68-year-old female patient received the booster dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via unspecified route on 29Sep2021 at 12:00 at patient age of 68-year-old as single dose (Lot Number: FF8839, Expiry Date: 27Oct2021) for COVID-19 immunisation. The patient received the booster dose due to surgery soon, having her hip replaced. The patient medical history and concomitant medications were not reported. The patient previously received BNT162B2 (COMIRNATY), dose 1 via unspecified route on 13Feb2021 at patient age of 67-year-old as single dose (Lot Number: EN6201) for COVID-19 immunisation and had no reaction. The patient previously received BNT162B2 (COMIRNATY), dose 2 via unspecified route on 06Mar2021 at patient age of 67-year-old as single dose (Lot Number: EN6198) for COVID-19 immunisation and experienced tired the next day after the dose, which recovered completely. At 4:00AM on 30Sep2021, the patient woke up with intense headache. Next day 01Oct2021, headache was even worse and almost blinding. On 02Oct2021, it continued that way. In back of head and front of eyes, feels like it was bulging. This continued on 03Oct2021. On 04Oct2021, the patient went to doctor thinking she was having a sinus infection and her face hurts so bad. Only time she felt relief was for a few minutes in a really hot shower. Having difficult sleeping because of it. Headache was still there, a little less. It was bothering her enough. Couldn't even fold laundry without having to lay back down. Would say disabling. Regarding headache, the patient also mentioned hard to keep eyes open, very light sensitive. When reading patient record card, the patient stated it was hard to focus, vision was so bad. The patient was also experiencing nausea from 30Sep2021 and loose stools from 02Oct2021. The patient had trouble eating because of the nausea. Nausea was still there. The patient was taking imodium for loose stools, but still ongoing. The patient was put on doxycycline thinking it was an infection. She had three doses of doxycycline and hasn't noticed a difference yet. The patient felt crummy and wants to crawl under a rock. The event headache was reported serious with seriousness criteria disabling/incapacitating. The events nausea and loose stools were reported serious with seriousness criteria medically significant. The reporter assessed the events headache, nausea and loose stools related to vaccine with method of assessment: global introspection. The patient was recovering from the event headache. The patient did not recover from the event nausea and loose stools. The outcome of the other events was not provided.
None. Pt. received PEDIARIX and Hep B (single dose) on 10-15-08.
received Havrix expired dose; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 42-year-old female patient who received HAV (Havrix) (batch number ABXB37AA, expiry date 31st July 2022) for prophylaxis.   On 8th August 2022, the patient received Havrix. On 8th August 2022, unknown after receiving Havrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 08-Aug-2022 Reporter's comment: The medical assistant reported that the patient received Havrix expired dose. The consent to follow up was given. Additional Supportive Information: The patient received expired dose of Havrix, which led to expired vaccine used.
pt presented 6 days p/2nd vax w/2 episodes of apnea & central cyanosis, & during eval in the hosp had a brief, generalized sz; subsequent eval led to identification & treatment for infantile spasms;
approximately 12 hours after vaccine was administered, patient experienced the following symptoms: severe chills and muscle aches; fever of 102.6 that did not respond to Tylenol, headache, vomiting, fatigue, shortness of breath, and chest tightness. She states  they lasted for approximately 18 hours, and have started improving in the past 24 hours. Still having symptoms of mild to moderate muscle aches and some shortness of breath. Using albuterol inhaler as needed. Patient is recovering at home currently.
This spontaneous report as received from a physician refers to unspecified number of male and female patients between 0 and 19 years of age. The reporter reported the patients were administered GARDASIL (lot# was not reported) and PNEUMOVAX23 (lot# was not reported) exposed to 31F for a cumulative total of 15 days from 01-APR-2013 to 23-MAY-2013. Other suspect therapies included M-M-R II (lot# was not reported). No adverse events reported. Additional information has been requested.
Patient experienced nausea and vomiting after receiving the vaccine. Patient also reported a lump around the injection site.
dose administered after vial appeared to have frost-like ring at the bottom after drawing up 5; This spontaneous case was reported by a physician and describes the occurrence of WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (dose administered after vial appeared to have frost-like ring at the bottom after drawing up 5) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (dose administered after vial appeared to have frost-like ring at the bottom after drawing up 5). At the time of the report, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (dose administered after vial appeared to have frost-like ring at the bottom after drawing up 5) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to US-MODERNATX, INC.-MOD-2021-095384, US-MODERNATX, INC.-MOD-2021-095367, US-MODERNATX, INC.-MOD-2021-095200, US-MODERNATX, INC.-MOD-2021-095633 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-095384: US-MODERNATX, INC.-MOD-2021-095367: US-MODERNATX, INC.-MOD-2021-095200: US-MODERNATX, INC.-MOD-2021-095633:
This spontaneous report was received from a licensed vocational nurse referring to a patient of unknown age and gender. Information on patient's pertinent medical history, drug reactions/allergies and concomitant therapies were not reported. On 30-MAY-2018, the patient was inadvertently vaccinated with an expired dose of PNEUMOVAX 23 injection (strength and dose were not reported) (lot # M040804, expiry date: 20-MAY-2018) intramuscularly for prophylaxis. No adverse effects were reported. There was no product quality complaint (PQC) reported.
I did not have an adverse reaction to the vaccine. I started feeling symptoms on 12/31/2022 with fever, runny nose, fatigue and muscle aches. I tested positive for COVID19 on 01/02/2022.  I got a prescription for Paxlovid from my provider.  I tolerated the medication without any problems.
Had adverse reaction to VAX1 a year ago.  BUT decided to try VAX again as getting too dangerous to not be fully vaccinated.  SOOOO,  took a half dose Pfizer VAX...and intend to take half doze Pfizer one week later. Because I am hypersensitive to meds.m drs felt a graded dose might be better at preventing side effects.  I had tests and am NOT allergic to the  vaccine.   I had no reaction problems at all with VAX2--- just like the first shot--- until many hours later.  This time, I did not swell up or have pounding heart. I slept just fine for 7 good hours.  Then, I had the most GOSH AWFUL night terror dream --- absolutely traumatic dream around 9 am.  I had night terrors with VAX1 and now have had night terrors with VAX2 Pfizer again.  There must be connection.  I also feel like fog-brain.  Mild diarrhea.  Am drinking lots of fluids. Took aspirin and allegra.  That is all. Doing okay-- just bad dreams!
Chest pain, palpitations, tightness of chest, shortness of breath, elevated heart rate (173) anxiety, panic attacks, full body tremors, tingling, hot sensation, sharp shooting pains especially in legs, chronic fatigue, dizziness, lightheadedness, feeling faint, cold sensation in hands and feet, Major brain fog, memory problems, trouble forming sentences, or finding words, vision problems, body weakness especially in legs.
Patient started to go pale, sweaty and cold after getting the vaccine. Dr. is called immediately. Patient comfortably lying flat and elevate his legs, cold cloth was applied behind the neck keep watching him and check his vitals 3 times, gave him coca cola and some crackers stayed inside the office for 1-2 hours until he started feeling totally fine.
This spontaneous report was received from a medical assistant regarding a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications and drug reactions/allergies were not provided. On an unspecified date in March 2018, reported as between the 8-MAR-2018 until 14-MAR-2018, the patient was vaccinated with and improperly stored dose of GARDASIL 9 injection, lot # N010497, expiration date 15-JAN-2020, for prophylaxis (route and anatomical location were not provided). The administered dose of the vaccine experienced a temperature excursion in the range between 47°F to 77°F during 55 minutes as recorded by a data logger. The vaccine had not had any previous temperature excursions. There was no adverse effect reported. Sender's Comments: US-009507513-1803USA006513: US-009507513-1803USA009619: US-009507513-1803USA009620: US-009507513-1803USA009621: US-009507513-1803USA009623: US-009507513-1803USA009624.
1st day - very sore arm of injection, dizziness, and fatigue.  2nd day - very sore arm, dizziness, extreme muscle fatigue, headache, nauseous, shortness of breath, and chest pains radiating to my left shoulder/arm.  At one point late in the evening of the 2nd day after the vaccine, I considered calling for medical assistnce.  I was unable to sleep well for the first 3 days after the vaccine.  3rd day -  sore arm, dizziness, extreme muscle fatigue, neck pain, headache, and nauseous.  4th day - fatigued and somewhat dizzy from time to time.